SI1121127T1 - Buprenorfin vsebujoča zdravila za oralno aplikacijo - Google Patents

Buprenorfin vsebujoča zdravila za oralno aplikacijo

Info

Publication number
SI1121127T1
SI1121127T1 SI9930736T SI9930736T SI1121127T1 SI 1121127 T1 SI1121127 T1 SI 1121127T1 SI 9930736 T SI9930736 T SI 9930736T SI 9930736 T SI9930736 T SI 9930736T SI 1121127 T1 SI1121127 T1 SI 1121127T1
Authority
SI
Slovenia
Prior art keywords
oral pharmaceutical
pharmaceutical compositions
compositions containing
buprenorphin
containing buprenorphin
Prior art date
Application number
SI9930736T
Other languages
English (en)
Inventor
Mauro Valenti
Original Assignee
Famraceutici Formenti S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Famraceutici Formenti S.P.A. filed Critical Famraceutici Formenti S.P.A.
Publication of SI1121127T1 publication Critical patent/SI1121127T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Emergency Medicine (AREA)
  • Physiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
SI9930736T 1998-10-16 1999-10-11 Buprenorfin vsebujoča zdravila za oralno aplikacijo SI1121127T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT1998MI002222A IT1302682B1 (it) 1998-10-16 1998-10-16 Composizioni farmaceutiche orali contenenti buprenorfina
EP99950690A EP1121127B1 (en) 1998-10-16 1999-10-11 Oral pharmaceutical compositions containing buprenorphin
PCT/EP1999/007595 WO2000023079A1 (en) 1998-10-16 1999-10-11 Oral pharmaceutical compositions containing buprenorphin

Publications (1)

Publication Number Publication Date
SI1121127T1 true SI1121127T1 (sl) 2005-06-30

Family

ID=11380880

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9930736T SI1121127T1 (sl) 1998-10-16 1999-10-11 Buprenorfin vsebujoča zdravila za oralno aplikacijo

Country Status (15)

Country Link
US (1) US6365596B1 (sl)
EP (1) EP1121127B1 (sl)
JP (1) JP2002527480A (sl)
AT (1) ATE287264T1 (sl)
AU (1) AU752449B2 (sl)
CA (1) CA2347195C (sl)
DE (1) DE69923336T2 (sl)
DK (1) DK1121127T3 (sl)
ES (1) ES2237165T3 (sl)
HU (1) HU226166B1 (sl)
IT (1) IT1302682B1 (sl)
NZ (1) NZ511085A (sl)
PT (1) PT1121127E (sl)
SI (1) SI1121127T1 (sl)
WO (1) WO2000023079A1 (sl)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002242705B2 (en) * 2001-02-16 2006-08-24 Gruenenthal Gmbh Utilization of buprenorphine in urinary incontinence therapy
US20140271788A1 (en) 2013-03-15 2014-09-18 Monosol Rx, Llc Sublingual and buccal film compositions
MXPA06011871A (es) 2004-04-15 2007-10-08 Chiasma Inc Composiciones capaces de facilitar la penetracion a traves de una barrera biologica.
EP1750675B1 (en) * 2004-06-02 2008-10-29 Galephar M/F Stable oral pharmaceutical compositions of buprenorphine and salt thereof
US20070117828A1 (en) * 2005-11-21 2007-05-24 Schering-Plough Animal Health Corp. Pharmaceutical compositions
EP1897543A1 (en) 2006-08-30 2008-03-12 Euro-Celtique S.A. Buprenorphine- wafer for drug substitution therapy
US20090270438A1 (en) * 2006-10-18 2009-10-29 Clive Booles Novel compositions and formulations
US20090082383A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched buprenorphine
WO2010032140A2 (en) 2008-09-17 2010-03-25 Chiasma Inc. Pharmaceutical compositions and related methods of delivery
GB2469792A (en) * 2009-04-23 2010-11-03 Calvin John Ross Oil-based pharmaceutical formulation for sublingual delivery
JP6210988B2 (ja) 2011-09-19 2017-10-11 オレクソ・アクチエボラゲット オピオイド依存を治療するための新規乱用耐性医薬組成物
US9867818B2 (en) 2013-09-10 2018-01-16 Insys Development Company, Inc. Sublingual buprenorphine spray
EP3043777B1 (en) 2013-09-10 2020-04-22 Fresh Cut Development, LLC Sublingual buprenorphine spray
US9839611B2 (en) 2013-09-10 2017-12-12 Insys Development Company, Inc. Sublingual buprenorphine spray
US9918981B2 (en) 2013-09-10 2018-03-20 Insys Development Company, Inc. Liquid buprenorphine formulations
US9642848B2 (en) 2014-07-08 2017-05-09 Insys Development Company, Inc. Sublingual naloxone spray
US10722510B2 (en) 2014-07-08 2020-07-28 Hikma Pharmaceuticals Usa Inc. Liquid naloxone spray
US10617686B2 (en) 2014-07-08 2020-04-14 Hikma Pharmaceuticals Usa Inc. Liquid naloxone spray
MA41462A (fr) 2015-02-03 2021-05-12 Chiasma Inc Méthode de traitement de maladies
ES2965836T3 (es) 2018-01-22 2024-04-17 Foresee Pharmaceuticals Co Ltd Composición farmacéutica para administración de liberación mantenida de buprenorfina
US11141457B1 (en) 2020-12-28 2021-10-12 Amryt Endo, Inc. Oral octreotide therapy and contraceptive methods

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4605671A (en) 1984-09-28 1986-08-12 American Home Products Corporation Parenteral formulation
JPH03275622A (ja) * 1990-03-26 1991-12-06 Teisan Seiyaku Kk マレイン酸トリメブチンを含有する経口固形製剤
JPH08295637A (ja) * 1995-04-27 1996-11-12 Green Cross Corp:The 口腔部局所投与剤
PT914097E (pt) * 1996-03-12 2002-06-28 Alza Corp Composicao e forma de dosagem compreendendo antagonista de opioide
JP3687025B2 (ja) * 1998-06-04 2005-08-24 東和薬品株式会社 安定なマレイン酸エナラプリル錠剤

Also Published As

Publication number Publication date
ITMI982222A0 (it) 1998-10-16
PT1121127E (pt) 2005-03-31
US6365596B1 (en) 2002-04-02
EP1121127B1 (en) 2005-01-19
DE69923336T2 (de) 2005-05-25
HU226166B1 (en) 2008-05-28
CA2347195C (en) 2008-03-18
IT1302682B1 (it) 2000-09-29
DK1121127T3 (da) 2005-05-02
NZ511085A (en) 2002-10-25
AU752449B2 (en) 2002-09-19
JP2002527480A (ja) 2002-08-27
HUP0103924A3 (en) 2003-05-28
AU6337199A (en) 2000-05-08
DE69923336D1 (de) 2005-02-24
WO2000023079A1 (en) 2000-04-27
HUP0103924A2 (hu) 2002-02-28
ATE287264T1 (de) 2005-02-15
EP1121127A1 (en) 2001-08-08
ES2237165T3 (es) 2005-07-16
CA2347195A1 (en) 2000-04-27
ITMI982222A1 (it) 2000-04-16

Similar Documents

Publication Publication Date Title
SI1121127T1 (sl) Buprenorfin vsebujoča zdravila za oralno aplikacijo
EP0960621A3 (en) Pharmaceutical formulations comprising sildenafil
ZA200206905B (en) Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same.
WO2000007979A3 (en) Compounds and compositions for delivering active agents
HK1043064A1 (en) Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics
HUP0102676A3 (en) Solid, quick dissolving pharmaceutical compositions containing cetrizine
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
HUP0401638A3 (en) Thiopene-amides, thiazolesulfonamides as antineoplastic agents, and pharmaceutical composition containing the same
CA2366679A1 (en) Stabilized oral pharmaceutical composition containing iodide and iodate and method
HUP0400832A3 (en) New amidoalkyl-piperidine and amidoalkyl-piperazine derivatives, and pharmaceutical compositions containing such derivatives as active ingredients
HK1045113A1 (zh) 給予固定的曲馬朵和雙氯酚酸組合的口服給藥形式
PL348419A1 (en) Sustained-release pharmaceutical preparation containing tilidine mesylate as active ingredient
EP2308479A3 (en) Compounds and compositions for delivering active agents
AU2002309038A1 (en) Compositions for transmucosal administration containing coenzyme Q as the active ingredient
HUP0103431A3 (en) Pharmaceutical, oral compositions containing 5-ht4 agonists or antagonists as active agent
AU5892399A (en) 1, 2, 4-triazole-3-thione compounds
ZA200110150B (en) Streptogramin derivatives, preparation and compositions containing them.
HUP0303673A3 (en) Piperidine derivatives and pharmaceutical compositions containing these derivatives as the active ingredient
AU4317500A (en) Antibiral compositions containing phorbol derivatives as the main active ingredient
EP1273301A3 (en) Pharmaceutical preparations based on active ingredients susceptible to illict administration
IL154986A0 (en) Triazolo-epothilone derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof
WO2002004012A8 (en) Anhydrous pharmaceutical composition of vancomycin for topical use
AU2882699A (en) Stabilizing composition for pharmaceutical dosage forms
HUP0303714A3 (en) Pharmaceutical compositions for dementia remedies containing 2-aryl-8-oxodihydropurine derivatives as the active ingredient
ZA200110073B (en) 14β-H-Sterols, pharmaceutical compositions comprising them and use of these derivatives for the preparation of meiosis regulating medicaments.